These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15686457)

  • 1. Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.
    Cordano P; Lake A; Shield L; Taylor GM; Alexander FE; Taylor PR; White J; Jarrett RF
    Br J Haematol; 2005 Feb; 128(4):493-5. PubMed ID: 15686457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
    Hohaus S; Giachelia M; Massini G; Vannata B; Criscuolo M; Martini M; D'Alo' F; Voso MT; Larocca LM; Leone G
    Leuk Res; 2009 Oct; 33(10):1352-6. PubMed ID: 19201467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
    Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
    Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epstein-Barr virus and Hodgkin's lymphoma].
    Hjalgrim H; Munksgaard L; Melbye M
    Ugeskr Laeger; 2002 Dec; 164(50):5924-7. PubMed ID: 12553111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.
    Hjalgrim H; Ekström-Smedby K; Rostgaard K; Amini RM; Molin D; Hamilton-Dutoit S; Schöllkopf C; Chang ET; Ralfkiaer E; Adami HO; Glimelius B; Melbye M
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1561-6. PubMed ID: 17684129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.
    da Silva GN; Bacchi MM; Rainho CA; de Oliveira DE
    Arch Pathol Lab Med; 2007 Nov; 131(11):1691-6. PubMed ID: 17979488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
    Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
    Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.
    Baran W; Szepietowski JC; Mazur G; Baran E
    Acta Derm Venereol; 2008; 88(2):113-6. PubMed ID: 18311435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
    Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
    Qi T; Wang Q; Zheng L; Yang HL; Bao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma.
    Hohaus S; Di Ruscio A; Di Febo A; Massini G; D'Alo' F; Guidi F; Mansueto G; Voso MT; Leone G
    Clin Cancer Res; 2005 Mar; 11(6):2175-9. PubMed ID: 15788664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population.
    Maver A; Medica I; Salobir B; Sabovic M; Tercelj M; Peterlin B
    Int J Mol Med; 2007 Sep; 20(3):385-90. PubMed ID: 17671745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.